Transposon-based, targeted ex vivo gene therapy to treat age-related macular degeneration (TargetAMD)

Item Type:	Article
Title:	Transposon-based, targeted ex vivo gene therapy to treat age-related macular degeneration (TargetAMD)
Creators Name:	Thumann, G. and Perdikomati-Dahmen, M. and Izsvák, Z. and Ivics, Z. and Garcia Layana, A. and Ronchetti, M. and Petrovski, G. and Scherman, D. and Aranda, P. and Pouillot, S. and Binder, S. and Johnen, S. and van den Berg, J.
Keywords:	Cell Line, DNA Transposable Elements, Eye Proteins, Genetic Therapy, Iris, Macular Degeneration, Nerve Growth Factors, Pigment Epithelium of Eye, Retina, Serpins, Animals, Cattle
Source:	Human Gene Therapy Clinical Development
ISSN:	2324-8637
Publisher:	Mary Ann Liebert
Volume:	26
Number:	2
Page Range:	97-100
Date:	18 June 2015
Additional Information:	Zsuzsanna Izsvak is a partner of the TargetAMD consortium.
Official Publication:	https://doi.org/10.1089/humc.2015.2519
PubMed:	View item in PubMed

Repository Staff Only: item control page